Axi-Cel Moves Toward the First-Line Setting for High-Risk Large B-Cell Lymphoma
Are patients who have received fewer prior medications better candidates for the receipt of CAR-T therapies?
Next post in Lymphoma
Are patients who have received fewer prior medications better candidates for the receipt of CAR-T therapies?
